±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1650  |  »Ø¸´: 5

Ò¶Õæìõ

гæ (³õÈëÎÄ̳)

[ÇóÖú] ×¢ÉäÓÃßßÀ­Î÷ÁÖÄÆ

Ë­Äܰïæ²éÒ»ÏÂ×¢ÉäÓÃßßÀ­Î÷ÁÖÄÆµÄÔ­ÑÐÆóÒµÊÇÄĸöÆóÒµ£¬»¹ÓйúÍâÉÏÊÐÇé¿ö°¡£¬Ð»Ð»´ó¼ÒÀ²£¡±¾ÈËÄÜÁ¦ÓÐÏÞ£¬µ½ÏÖÔÚ»¹Ã»²éµ½¡£×¢ÉäÓÃßßÀ­Î÷ÁÖÄÆ   Ô­ÑÐÆóÒµ  ¹úÍâÉÏÊÐ
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒþÒþÔ¼Ô¼ÒþÒþÔ¼Ô¼ÒþÒþÔ¼Ô¼ÒÚÔª
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

fengzi913

ľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
³ÕÒÄ×ÓÆ¤: ½ð±Ò+1, ¸Ðл»ØÌû½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2013-07-31 13:17:31
Drug Name(s)        ZOSYN
FDA Application No.        (NDA) 050684
Active Ingredient(s)        PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Company        WYETH PHARMS INC
Original Approval or Tentative Approval Date        October 22, 1993
Chemical Type         1  New molecular entity (NME)
4  New combination
Review Classification         S  Standard review drug
2Â¥2013-07-31 09:18:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wuxw126

Òø³æ (ÕýʽдÊÖ)

ÎÒÒ²ÏëÖªµÀÕâ¸ö´ð°¸£¬Ö§³ÖÒ»ÏÂ
ÒòΪºÃÆæËùÒÔϲ»¶
3Â¥2014-09-12 15:53:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wuxw126

Òø³æ (ÕýʽдÊÖ)

Â¥Ö÷ÒªÊÇÒѾ­ÖªµÀ´ð°¸ÁË£¬Çë·ÖÏíһϣ¬Ð»Ð»
ÒòΪºÃÆæËùÒÔϲ»¶
4Â¥2014-09-12 16:00:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nyj1116

½ð³æ (СÓÐÃûÆø)

δÀ´¾«Ó¢

ÒýÓûØÌû:
2Â¥: Originally posted by fengzi913 at 2013-07-31 09:18:53
Drug Name(s)        ZOSYN
FDA Application No.        (NDA) 050684
Active Ingredient(s)        PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Company        WYETH PHARMS INC
Original Approval or Tentative Approval Date        October 22, 1 ...

ÏëÎÊһϣ¬ÄúÊÇ´ÓÄĶù²éµ½µÄ£¬ÄܸæÖªÒ»ÏÂÂð£¿Ð»Ð»
°®ÎÊÎÊÌâµÄСÃÛ·ä
5Â¥2015-12-13 22:22:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

fengzi913

ľ³æ (ÕýʽдÊÖ)

ÒýÓûØÌû:
5Â¥: Originally posted by nyj1116 at 2015-12-13 22:22:56
ÏëÎÊһϣ¬ÄúÊÇ´ÓÄĶù²éµ½µÄ£¬ÄܸæÖªÒ»ÏÂÂð£¿Ð»Ð»...

http://www.drugfuture.com/fda/
ºÃÏñÊÇÕâ¸ö°É£¬Ê±¼äÌ«¾ÃÁ˼Dz»µÃÁË
6Â¥2015-12-14 11:59:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Ò¶Õæìõ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 070300Çóµ÷¼Á306·Ö +3 26ÒªÉϰ¶ 2026-03-27 3/150 2026-03-27 17:57 by arrow8852
[¿¼ÑÐ] 08¿ªÍ·275Çóµ÷¼Á +4 À­Ë­²»ÖØÒª 2026-03-26 4/200 2026-03-27 14:12 by Delta2012
[¿¼ÑÐ] 298µ÷¼Á +3 jiyingjie123 2026-03-27 3/150 2026-03-27 11:57 by wxiongid
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤¿¼Ñе÷¼Á +16 ‹üÈA 2026-03-22 16/800 2026-03-27 11:23 by ÍõЦÓîÒ»¶¨ÊÇÑо
[¿¼ÑÐ] 325Çóµ÷¼Á +5 Àî¼Îͼ¡¤S¡¤Â· 2026-03-23 5/250 2026-03-27 00:42 by wxiongid
[¿¼ÑÐ] µ÷¼ÁÇóÊÕÁô +7 ¹ûÈ»ÓÐÎÒ 2026-03-26 7/350 2026-03-27 00:26 by wxiongid
[¿¼ÑÐ] Ò»Ö¾Ô¸±±»¯Çóµ÷¼Á +3 Jsman 2026-03-22 3/150 2026-03-26 21:06 by ajpv·çÀ×
[¿¼ÑÐ] Ò»Ö¾Ô¸ÏÃÃÅ´óѧ»¯Ñ§Ñ§Ë¶307Çóµ÷¼Á +8 y7czhao 2026-03-26 8/400 2026-03-26 19:51 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 085602 289·ÖÇóµ÷¼Á +8 WWWÎ÷Î÷¸¥Ë¹ 2026-03-24 8/400 2026-03-26 16:33 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì 317Çóµ÷¼Á +4 JKSOIID 2026-03-26 4/200 2026-03-26 15:58 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ×Ü·Ö293Çóµ÷¼Á +6 ¼ÓÒ»Ò»¾Å 2026-03-25 8/400 2026-03-26 13:30 by yujianx
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧ»¯Ñ§Ñ§Ë¶0703×Ü·Ö337Çóµ÷¼Á +7 niko- 2026-03-22 7/350 2026-03-25 20:14 by qingfeng258
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á +3 Çñgl 2026-03-25 3/150 2026-03-25 19:03 by Ainin_
[¿¼ÑÐ] 289²ÄÁÏÓ뻯¹¤£¨085600£©BÇøÇóµ÷¼Á +4 ÕâôÃû×ÖÕ¦Ñù 2026-03-22 5/250 2026-03-25 08:20 by mx.yue
[¿¼ÑÐ] 292Çóµ÷¼Á +4 ¶ì¶ì¶ì¶î¶î¶î¶î¶ 2026-03-24 4/200 2026-03-24 16:41 by peike
[¿¼ÑÐ] 384Çóµ÷¼Á +3 ×Óϵ²© 2026-03-22 6/300 2026-03-23 21:45 by ×Óϵ²©
[¿¼ÑÐ] 276Çóµ÷¼Á +3 YNRYG 2026-03-21 4/200 2026-03-23 08:31 by ×íÔÚ·çÀï
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 ºôºô£¿~+123456 2026-03-21 3/150 2026-03-21 20:04 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ÇóÖú +5 ÃÎÀïµÄÎÞÑÔ 2026-03-21 6/300 2026-03-21 17:51 by ѧԱ8dgXkO
[¿¼ÑÐ] 085601µ÷¼Á 358·Ö +3 zzzzggh 2026-03-20 4/200 2026-03-21 10:21 by luoyongfeng
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û